1. Medtech Insight
  2. >>Policy & Regulation
  3. >>Approvals

New Products In Brief

Recent market launches include iWalk’s BiOM AK bionic ankle, Mevion’s S250 proton beam radiation therapy system and Smith & Nephew’s Truclear 5.0 for polyps removal.

Bionic lower limb system for above-knee amputees launches in the U.S., Bedford, Mass.-based BionX Medical Technologies Inc. announced June 12. The BiOM AK ankle system is intended to work with select microprocessor knees to restore natural motion through personalized bionic technology. It is “the world’s first proven bionic intervention that utilizes robotics to restore the function of the missing anatomy in the calf muscle and Achilles tendon,” iWalk states. The system, a class II, 510(k)-exempt device registered with FDA, is designed to deliver a powered “push-off” to propel the wearer forward and normalize his or her gait. The previous version of the device, BiOM, launched last year for below-knee amputees. Computerized bionic leg technology was highlighted by the Cleveland Clinic last year as one of seven up-and-coming device technologies likely to have major clinical impact in the near future. (See Also see "Devices Rank Front And Center In Cleveland Clinic’s 'Top 10' Picks" - Medtech Insight, 10 October, 2011..)

The BiOM AK bionic ankle is designed to deliver a powered “push-off” to propel an amputee forward and normalize his or her gait.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Approvals

First At-Home Cervical Cancer Screening Tool Gets FDA Clearance

 
• By Elizabeth Orr

The US FDA has approved the Teal Wand, the first at-home cervical cancer screening device. Capable of detecting preclinical cancer with 96% accuracy, it will launch in California in June and expand nationwide soon after.

New Treatment For Chronic Facial Pain Could Launch By Fall 2025

 
• By Elizabeth Orr

NeuroOne is preparing to submit its OneRF Trigeminal Nerve Ablation System to the US FDA for treating trigeminal neuralgia, a chronic facial pain condition. CEO Dave Rosa told Medtech Insight that he expects a possible product launch by fall 2025.

Precision Neuroscience’s FDA Clearance For Core Component Of Brain Implant Expected to Accelerate R&D

 
• By Marion Webb

Precision’s recent FDA clearance for a core part of its next-generation wireless brain-computer interface system opens the pathway to a safer, more humane BCI for researchers to use compared to higher-risk intracortical arrays, according to BCI expert Naveen Rao.

Edwards Mitral Valve Replacement System SAPIEN M3 Receives CE Mark

 
• By Natasha Barrow

“We believe [the SAPIEN M3] launch alongside PASCAL and EVOQUE will help support the company’s target of $2bn in transcatheter mitral and tricuspid therapies sales by 2030,” noted analysts from Leerink Partners.

More from Policy & Regulation

Zika Virus Test Among 4 New FDA Device Classifications

 
• By Elizabeth Orr

The FDA plans to announce class II status for four new device types, including tests for the Zika virus and genetic condition Fragile X. This follows earlier announcements and highlights a trend toward diagnostic classifications. The classifications are considered deregulatory, meaning they will hel

FDA Draft Guidance Introduces Electric Submission For Q-Sub Process

 
• By Brian Bossetta

The US FDA says its updated draft guidance represents one of several steps the agency is taking to develop electronic submission templates for the medical device industry. The document introduces stakeholders to currently available resources for supporting their pre-subs to the agency.

Industry Execs Talk Tariff Turbulence During MD&M East

 
• By Brian Bossetta

During MD&M East in Manhattan last week, a panel of experts discussed how the Trump administration’s trade policy is affecting manufacturing and offered some ideas on what manufacturers can do to help mitigate the chaos.